The National AIDS Trust (NAT) is the UK’s leading charity dedicated to transforming society’s response to HIV. They provide fresh thinking, expertise and practical resources. They champion the rights of people living with HIV and campaign for change. Shaping attitudes. Challenging injustice. Changing lives.
When, after 18 months of preparation, NHS England suddenly abandoned its work on PrEP, NAT considered it had no option but to challenge this through judicial review. Today the court heard that NHS England’s interpretation of the law was incorrect. PrEP is urgently needed and has been shown to be cost-effective. NAT has always believed that there is no legal impediment to PrEP being commissioned by NHS England and the court agrees.
Pre-Exposure Prophylaxis (PrEP) involves HIV negative people taking an antiretroviral drug to avoid getting HIV.
Multiple studies around the world have shown PrEP to be highly effective in reducing the risk of contracting HIV. The results of the PrOUD trial in England, released in 2015, prove that PrEP works and that concerns about it not working in a real world setting, were unfounded. Read more about the trial here: http://www.proud.mrc.ac.uk/
Most trials of PrEP and the US CDC Guidelines involve taking PrEP daily. A study in France, ANRS IPERGAY, has looked at the efficacy of PrEP when taken ‘on demand’, in other words not daily but only before and after sex. There was also significant preventive benefit shown in this trial.